130P - Positron emission tomography (PET) as a prognostic factor in malignant pleural mesothelioma (MPM)

Date 28 March 2014
Event ELCC 2014
Session Lunch and poster display session
Topics Mesothelioma
Imaging, Diagnosis and Staging
Presenter Susana Cedres
Citation Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131
Authors S. Cedres1, S. Ponce2, J. Zugazagoitia2, A. Navarro3, A. Martinez4, P. Martinez4, F. Salva3, C. Muñoz2, G. Ruiz Ares2, E. Felip5
  • 1Medical Oncology, Vall d´Hebron University Hospital. Universidad Autonoma de Barcelona, 08029 - barcelona/ES
  • 2Medical Oncology, Hospital 12 Octubre. Universidad Complutense, 28041 - Madrid/ES
  • 3Medical Oncology, Vall d´Hebron University Hospital, 08029 - barcelona/ES
  • 4Medical Oncology, Vall d´Hebron University Hospital. Universidad Autonoma de Barcelona, 08029 - barcelona/ES
  • 5Oncologia Médica, Vall d`Hebron University Hospital Institut d'Oncologia, Barcelona/ES

Abstract

Malignant pleural mesothelioma (MPM) is an aggressive tumor linked to asbestos exposure and a marked increase in the incidence is predicted over the next decades in Europe and developing nations. We investigated the overall survival (OS) and variables affecting survival in patients (p) diagnosed of MPM.